SCN1A rs6732655A/T polymorphism: Diagnostic and therapeutic insights for drug-resistant epilepsy

doi:10.5493/wjem.v14.i3.94999

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1354)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

HTML

730

Figures (1-2)

153

Tables (1-5)

155

Sum=1094

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

144

Sum=201

Sep 20, 2024 (publication date) through Feb 7, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Exp Med. Sep 20, 2024; 14(3): 94999
Published online Sep 20, 2024. doi: 10.5493/wjem.v14.i3.94999

Table 5 Receiver operating characteristic analysis of interleukin-1β and interleukin-6

Factor	AUC	Asymptotic 95%CI		Optimum cutoff	Sensitivity	Specificity	P value
Factor	AUC	Lower bound	Upper bound	Optimum cutoff	Sensitivity	Specificity	P value
IL-1β	0.880	0.808	0.952	59.52	80.0%	100%	< 0.001
IL-6	0.869	0.795	0.943	4.63	86.0%	86.0%	< 0.001

AUC: Area under curve; CI: Confidence interval; IL-1β: Interleukin-1β; IL-6: Interleukin-6.

Citation: Viswas A, Dabla PK, Shrivastav D, Gupta S, Yadav M, Yadav S, Koner BC. SCN1A rs6732655A/T polymorphism: Diagnostic and therapeutic insights for drug-resistant epilepsy. World J Exp Med 2024; 14(3): 94999
URL: https://www.wjgnet.com/2220-315x/full/v14/i3/94999.htm
DOI: https://dx.doi.org/10.5493/wjem.v14.i3.94999